MedDataX Logo

Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy

NCT ID: NCT00253253

Last Updated: 2008-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

181 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-08-31

Study Completion Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the long-term outcome in congenital undescended testis after surgical treatment by orchidopexy and to what extent orchidopexy is the treatment for congenital undescended testis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Undescended Testis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

orchidopexy, long-term outcome, congenital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The orchidopexy has taken place in the Medical Center Alkmaar between 1986-2004
* The indication concerned a congenital undescended testis
* It concerns a first orchidopexy to the concerning testis

Exclusion Criteria

* Orchidopexy has taken place on an other reason than congenital undescended testis (for example: torsio testis)
* It concerns re-orchidopexy
Minimum Eligible Age

6 Months

Maximum Eligible Age

25 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical Center Alkmaar

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

W.W. M. Hack, MD, PhD

Role: STUDY_DIRECTOR

Department of Pediatrics, Medical Centre Alkmar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Center Alkmaar

Alkmaar, North Holland, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P05.936L

Identifier Type: -

Identifier Source: org_study_id